The briefing
A Northland nurse with a rare hereditary cancer has turned to donations to access ripretinib after Pharmac declined funding. The high cost of the drug has become a focal point in her fight to extend treatment time.
Original headline
Pharmac rejects ripretinib funding for Whangārei nurse with rare cancer